Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Making simple things complicated using anti-inflammatory reliever therapy
Brian Lipworth, Chris RuiWen Kuo, Rory Chan
Eur Respir J, 55 (4) 2000267; 10.1183/13993003.00267-2020
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Brian Lipworth, Chris RuiWen Kuo, Rory Chan. Making simple things complicated using anti-inflammatory reliever therapy. Eur Respir J, 55 (4) 2000267; 10.1183/13993003.00267-2020
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Budesonide/formoterol maintenance and reliever therapy for asthma in general practice: is it cost-effective?
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Formoterol as relief medication is increasingly more effective than salbutamol in patients with increasing need for reliever therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 235s
How to treat asthma in 2021? Goodbye SABA, hello MART and welcome triple therapy
Source: Virtual Congress 2021 – Airway diseases
Use of relievers in patients with severe asthma on biologic therapy –a multidisciplinary approach
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Oral corticosteroids for asthma usually prescribed by non-specialists
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Time to ban short-acting ß-agonists and use anti-inflammatory treatment as required to improve outcomes
Source: Virtual Congress 2021 – Wheezing illnesses along the life span
Next generation of anti-inflammatory therapy for COPD?
Source: Eur Respir J, 50 (4) 1702084; 10.1183/13993003.02084-2017
Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy?
Source: Eur Respir J 2004; 24: 1-2
Budesonide/formoterol single inhaler therapy reduces overreliance on rapid-acting reliever medication
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Can " Beta-blockers" be useful to treat asthma?
Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
How often do asthma patients claim prescribed therapy?
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment
Source: Eur Respir J 2015; 45: 260-262
Optimising bronchodilator therapy in COPD: Who, why and when?
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
How effective are oral steroids in asthma action plans?
Source: International Congress 2017 – Asthma management
How can we minimise the use of regular oral corticosteroids in asthma?
Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019
Is it time to move away from short-acting beta-agonists in asthma management?
Source: Eur Respir J, 53 (4) 1802223; 10.1183/13993003.02223-2018
Investigating the steroids and long-acting β2-agonists combination: why do we need more?
Source: Eur Respir J 2004; 23: 501-502
Budesonide/formoterol maintenance and reliever therapy compared to conventional best practice in the treatment of persistent asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 616s
Is there a problem with oral corticosteroid use in asthma?
Source: Virtual Congress 2020 – Airway diseases